AOD-9604 mg to units converter

AOD-9604 is a peptide fragment, a term for a small chain of amino acids. Specifically, it’s a modified piece of the tail end of human growth hormone (hGH), containing the amino acid sequence 177-191. This fragment was isolated because scientists observed that the fat-burning effects of hGH seemed to be located in this specific part of the hormone molecule. The goal of its development was to create a substance that could offer the lipolytic (fat-releasing) benefits of hGH without the other, sometimes unwanted, effects. These other effects include things like muscle growth, changes in insulin sensitivity, or an increase in the hormone IGF-1. By creating this fragment, researchers aimed to build a more targeted tool focused purely on fat metabolism.

The development of AOD-9604—which stands for Anti-Obesity Drug—was undertaken by an Australian biotechnology company. Their research focused on creating a compound that could mimic the natural fat-processing action of hGH. Because it doesn’t contain the full sequence of the growth hormone molecule, it does not bind to the hGH receptor. This is a crucial distinction. It means that AOD-9604 is not simply a smaller version of hGH; it’s a distinct peptide that interacts with the body in a much more specific way. This has made it a subject of interest for people who are focused on body composition and fat loss, but who do not want the broader systemic effects that come with administering full-length growth hormone.

In the research market, AOD-9604 is typically sold as a lyophilized, or freeze-dried, white powder in glass vials. This form keeps the peptide stable for shipping and storage. Common vial sizes include 2mg, 5mg, or sometimes 10mg of the peptide. To be used, this powder must be reconstituted, a process of mixing it with a sterile liquid like bacteriostatic water. The resulting solution is then clear and can be dosed with an insulin syringe. The concentration of the final liquid depends entirely on how much water is added, which is why accurate measurements are so important for consistent tracking, a process this app helps simplify. The 5mg vial is a very common size that researchers and individuals often work with.

The mechanism of AOD-9604 is quite unique and is the primary reason it was developed. Unlike human growth hormone (hGH), AOD-9604 does not work by binding to the official hGH receptor. This means it doesn’t trigger the downstream signaling that leads to the release of IGF-1, muscle cell growth, or potential impacts on insulin sensitivity. Instead, its action is believed to be much more focused. The peptide is thought to directly interact with fat cells to kickstart a process called lipolysis, which is the breakdown of stored fats (triglycerides) into free fatty acids that the body can then use for energy. It essentially encourages fat cells to release their contents.

At the same time it’s stimulating fat release, AOD-9604 is also thought to inhibit lipogenesis—the body’s process of creating and storing new fat. So, it’s believed to work from two sides: helping to burn existing fat while also working to prevent new fat from accumulating. This dual action is what makes it a compelling subject of study for fat loss. One of the proposed pathways for this action is through the beta-3 adrenergic receptors, which are found in high concentrations on fat cells. Activation of these receptors is known to initiate fat breakdown. AOD-9604 is thought to be an agonist of these receptors, effectively flipping the switch that tells fat cells to start breaking down.

This targeted mechanism is what sets AOD-9604 apart. While hGH has powerful fat-loss properties, it also comes with a host of other systemic effects because it influences so many different cell types throughout the body. For individuals whose primary goal is to change body composition by reducing fat mass, the other effects of hGH might be unnecessary or even unwanted. AOD-9604 was engineered to strip away those other functions and isolate just one: the regulation of fat. Early clinical trials explored whether this peptide could produce measurable fat loss in obese individuals without adversely affecting blood sugar levels or causing tissue growth, which the data suggested was the case.

The Peptide Pilot app is designed to make tracking your AOD-9604 protocol simple and accurate. When you first get your vial, you’ll start by setting up a new peptide in the app. You’ll enter the total amount of peptide in the vial—for example, 5mg. Next, you’ll enter the amount of diluent (bacteriostatic water) you used for reconstitution, such as 2mL. The app instantly calculates the resulting concentration for you, so you know exactly how many milligrams of AOD-9604 are in every milliliter or unit of your solution. This one-time setup removes the need for manual calculations every time you prepare a dose.

Each day, you’ll log your dose in the app. Let’s say your target is 0.3mg. You can simply enter "0.3mg" as your dose amount. Based on the vial information you entered earlier, the app will automatically tell you how many units that corresponds to on an insulin syringe—in this case, 12 units. This feature helps eliminate the most common source of error: incorrect dose calculation. You just draw up the specified number of units and you can be confident you’re administering the exact amount you intended to. You can also add notes to each entry, such as the time of day or whether you took it in a fasted state, to add more context to your log.

Beyond just logging doses, the app serves as a comprehensive journal for your entire protocol. Since AOD-9604 is used for body composition, you can use the app’s tracking features to monitor relevant metrics. You might log your body weight daily, or take weekly measurements of your waist, hips, or other areas. If you have access to a smart scale or body fat caliper, you can also log your body fat percentage. Over time, you can view this data in graphs alongside your dosing history, giving you a clear visual representation of your journey and helping you assess how your AOD-9604 protocol correlates with the changes you’re observing.